Ethics and Future Biotechnology
5. Future Challenges and Opportunities
Learning outcomes
- I can identify emerging trends in biotechnology.
- I can explain how biotechnology may address future global challenges.
- I can evaluate potential risks associated with new technologies.
- I can analyze scientific and societal impacts of biotechnology innovations.
- I can predict future applications of biotechnology using current evidence.
Biotechnology has already transformed medicine, agriculture, food production, industry, and environmental management. Technologies such as genetic engineering, CRISPR, recombinant DNA, stem cells, DNA sequencing, vaccines, fermentation, and bioremediation are now widely used or actively researched.
But biotechnology is still developing rapidly.
Future biotechnology may help address some of humanity's largest challenges, including:
- emerging diseases
- genetic disorders
- cancer
- food security
- climate change
- environmental pollution
- antibiotic resistance
- aging populations
- shortages of organs for transplantation
- sustainable manufacturing
At the same time, increasingly powerful biological technologies create new questions involving safety, ethics, privacy, access, environmental impact, regulation, and fairness.
Understanding biotechnology's future therefore requires us to consider both:
opportunities + challenges
Predicting the Future of Biotechnology
Scientists cannot know exactly what biotechnology will look like decades from now.
However, we can make evidence-based predictions.
A scientific prediction should be based on:
- technologies that already exist
- current research
- demonstrated capabilities
- known limitations
- observable trends
For example, CRISPR can already edit particular DNA sequences.
Therefore, it is reasonable to predict:
Gene-editing technologies will probably become increasingly important in treating some genetic diseases.
It would be much less scientifically justified to claim:
Gene editing will eliminate all genetic diseases.
The second statement ignores biological complexity, technical limitations, cost, access, and environmental factors.
Emerging Trend 1: More Precise Gene Editing
CRISPR-Cas9 transformed gene editing by allowing researchers to target particular DNA sequences.
Newer technologies are expanding these capabilities.
Examples include:
- base editing
- prime editing
- epigenome editing
- improved CRISPR systems
Traditional CRISPR-Cas9 editing often involves creating a DNA break.
Some newer approaches can make particular changes without conventional double-stranded DNA cutting.
Potential future improvements include:
- greater precision
- fewer unintended changes
- improved delivery
- editing more cell types
- treating more genetic disorders
Opportunity: Treating Genetic Disease
Thousands of human diseases have genetic components.
Some result largely from variants in a single gene.
Gene editing could potentially:
identify harmful genetic variant
↓
target affected cells
↓
modify DNA or gene activity
↓
restore or compensate for biological function
This could move medicine beyond repeatedly treating symptoms toward addressing underlying biological causes in some diseases.
Challenge: Delivering Gene Editors
Knowing what DNA sequence to edit is only part of the problem.
Scientists must also deliver the editing system to the correct cells.
Imagine treating a genetic condition affecting the brain.
The editing system must:
- enter the body safely
- reach the appropriate tissue
- reach enough target cells
- enter those cells
- perform the intended edit
- avoid unacceptable effects elsewhere
Delivery remains one of the major challenges in gene-editing medicine.
Emerging Trend 2: Personalized Medicine
People vary genetically.
These genetic differences can sometimes influence:
- disease risk
- drug metabolism
- treatment response
- side effects
Personalized medicine, also called precision medicine in many contexts, attempts to use biological information to help select more appropriate prevention or treatment strategies.
Future healthcare may increasingly combine:
genetic information + medical history + biomarkers + lifestyle/environmental information
to guide treatment.
Pharmacogenomics
Pharmacogenomics examines how genetic differences can influence responses to medicines.
Imagine two patients receive the same drug.
Patient A
Metabolizes the drug rapidly.
Patient B
Metabolizes the drug slowly.
The same dose could produce different drug concentrations and effects.
Genetic information may sometimes help doctors select:
- appropriate medicines
- safer doses
- alternative treatments
This could reduce trial-and-error prescribing in some areas of medicine.
Challenge: Genetic Privacy
Personalized medicine requires information.
Genetic information can be particularly sensitive because it may reveal information about:
- disease risk
- ancestry
- biological relationships
- inherited characteristics
It can also reveal information relevant to biological relatives.
Important questions include:
- Who owns genomic data?
- Who can access it?
- How long should it be stored?
- Can it be used for research?
- How is it protected?
- What happens if databases are breached?
Future biotechnology will therefore require advances in data protection as well as biology.
Emerging Trend 3: Regenerative Medicine
Regenerative medicine aims to repair or replace damaged tissues and organs.
Important technologies include:
- stem cells
- tissue engineering
- biomaterials
- organoids
- gene editing
- 3D bioprinting
Instead of simply treating damaged tissue, future medicine may increasingly attempt to regenerate it.
Organoids
An organoid is a three-dimensional collection of cells grown to reproduce some structural or functional features of an organ.
Scientists can grow organoids representing aspects of:
- intestine
- liver
- kidney
- brain
- lung
- other tissues
Organoids are not usually complete miniature organs.
However, they can provide useful biological models.
Applications of Organoids
Organoids can potentially help scientists:
- study development
- investigate disease
- test medicines
- study genetic disorders
- reduce some forms of animal experimentation
- investigate personalized treatment responses
For example:
patient cells
↓
patient-derived organoid
↓
several treatments tested
↓
response compared
↓
information may help guide treatment
This could contribute to personalized medicine.
Future Opportunity: Replacement Organs
Organ transplantation saves many lives, but suitable donor organs are limited.
Future biotechnology may help address this through:
- tissue engineering
- stem-cell-derived tissues
- improved artificial organs
- bioprinting
- genetically modified animal organs
Producing a fully functional complex human organ remains extremely difficult.
An organ requires:
- multiple cell types
- correct three-dimensional structure
- blood vessels
- nerves in some tissues
- mechanical properties
- integration with the patient's body
Therefore, simpler tissues may be achievable before fully engineered complex organs become routine.
Xenotransplantation
Xenotransplantation involves transplanting cells, tissues, or organs between different species.
One area of research involves genetically modifying pigs so their organs may become more compatible with human recipients.
Gene editing may help alter genes involved in:
- immune rejection
- compatibility
- other biological barriers
Potential benefit:
larger supply of transplantable organs
Potential challenges include:
- immune rejection
- infection risks
- long-term outcomes
- animal welfare
- ethical concerns
Emerging Trend 4: Synthetic Biology
Synthetic biology combines biology and engineering to design or redesign biological systems.
Traditional genetic engineering might modify one or several genes.
Synthetic biology can involve designing more complex:
- genetic circuits
- metabolic pathways
- engineered microorganisms
- biological production systems
The goal is often to make cells perform useful functions.
Cells as Biological Factories
Microorganisms can already produce many useful substances.
Future engineered organisms could potentially manufacture:
- medicines
- vaccines
- fuels
- food ingredients
- enzymes
- biodegradable materials
- industrial chemicals
Instead of:
petroleum → chemical factory → product
some products might increasingly use:
renewable biological feedstock → engineered microorganism → product
This is sometimes described as biomanufacturing.
Precision Fermentation
Traditional fermentation has been used for thousands of years to produce foods such as:
- bread
- yogurt
- cheese
- alcoholic beverages
Modern precision fermentation can use engineered microorganisms to produce specific molecules.
For example, microorganisms can potentially be programmed to produce particular:
- proteins
- enzymes
- fats
- food ingredients
This may become increasingly important in food and industrial biotechnology.
Emerging Trend 5: Cultivated Meat
Cultivated meat is produced by growing animal cells rather than raising and slaughtering an entire animal for its meat.
A simplified process is:
animal cells collected
↓
cells grown in controlled conditions
↓
cells multiply
↓
muscle and other tissues develop
↓
food product produced
Opportunities for Cultivated Meat
Potential benefits could include:
- reduced need for livestock
- reduced land requirements in some systems
- reduced animal slaughter
- more controlled production
- potentially reduced environmental impacts
However, actual environmental performance depends on how the product is manufactured.
Challenges for Cultivated Meat
Important challenges include:
- production cost
- energy requirements
- large-scale cell culture
- growth media
- texture
- consumer acceptance
- regulation
- food safety
Therefore:
"Cultivated meat uses fewer animals"
does not automatically mean:
"Cultivated meat always has a lower environmental impact."
A complete life-cycle assessment is required.
Emerging Trend 6: Climate-Resilient Crops
Climate change may increase:
- drought
- heat stress
- flooding
- soil salinity
- pest pressures
- disease pressures
Biotechnology may help develop crops that tolerate changing environmental conditions.
Potential traits include:
- drought tolerance
- heat tolerance
- salt tolerance
- disease resistance
- improved nutrient use
- improved water-use efficiency
Food Security
Food security means people have reliable access to sufficient safe and nutritious food.
Biotechnology could contribute through:
- improved crop resistance
- reduced food spoilage
- improved nutrition
- disease-resistant livestock
- alternative proteins
- improved fermentation
- better diagnostics for agricultural disease
However, food security also depends on:
- poverty
- distribution
- infrastructure
- conflict
- markets
- food waste
Biotechnology can contribute to food security, but it cannot solve every cause of hunger.
Emerging Trend 7: Biological Solutions to Pollution
Future environmental biotechnology may increasingly use:
- microorganisms
- enzymes
- plants
- engineered biological systems
to manage pollution.
Potential applications include:
- plastic recycling
- wastewater treatment
- oil pollution
- contaminated soil
- nutrient recovery
- carbon management
Enzymatic Plastic Recycling
Scientists are developing enzymes capable of breaking particular polymers into smaller molecules.
Potential future process:
plastic waste
↓
enzyme treatment
↓
chemical building blocks
↓
purification
↓
new materials
This could potentially support a more circular economy.
However, large-scale success depends on:
- reaction rates
- mixed waste
- contamination
- cost
- energy requirements
- collection systems
Emerging Trend 8: Carbon Biotechnology
Biological systems naturally interact with carbon dioxide.
Scientists are investigating ways to use:
- algae
- microorganisms
- engineered enzymes
- plants
to capture or transform carbon.
Possible products include:
- fuels
- chemicals
- biomass
- building materials
However, climate benefit depends on whether the overall process produces a meaningful net reduction in greenhouse gas emissions.
Emerging Trend 9: Biosensors
Future biotechnology may allow increasingly rapid detection of:
- pathogens
- toxins
- pollutants
- biomarkers
- food contamination
A biosensor combines biological recognition with a detectable signal.
Potential future systems could provide rapid monitoring in:
- hospitals
- homes
- farms
- factories
- water systems
- ecosystems
Emerging Trend 10: Rapid Diagnostics
Disease outbreaks can spread quickly.
Rapid biotechnology-based diagnostics can help identify:
- pathogens
- genetic sequences
- immune responses
- disease biomarkers
Earlier detection can support:
faster diagnosis
↓
earlier treatment
↓
better disease monitoring
↓
improved outbreak response
Portable diagnostic systems may become increasingly important in regions with limited laboratory infrastructure.
Emerging Trend 11: Faster Vaccine Development
Modern biotechnology has expanded the ways vaccines can be designed and manufactured.
Platforms include:
- recombinant proteins
- viral vectors
- nucleic-acid technologies
- other engineered biological systems
A major future goal is to create adaptable vaccine platforms.
Instead of developing every vaccine completely from the beginning, scientists may be able to modify an established platform to target a newly identified pathogen.
Emerging Trend 12: Fighting Antibiotic Resistance
Antibiotic resistance occurs when bacteria evolve mechanisms allowing them to survive antibiotic treatments.
It is a major global health challenge.
Biotechnology may contribute through:
- rapid diagnostics
- new antibiotics
- engineered antimicrobial molecules
- bacteriophage-based approaches
- improved surveillance
- microbiome research
Phage Therapy
Bacteriophages are viruses that infect bacteria.
Scientists are investigating whether selected phages could help treat some bacterial infections.
Potential advantage:
Some phages can target particular bacterial strains.
Potential limitations include:
- bacteria evolving resistance
- immune responses
- identifying appropriate phages
- manufacturing and regulation
Phage therapy illustrates an important idea:
Future medicine may sometimes use biological organisms to fight other biological organisms.
Emerging Trend 13: The Human Microbiome
The human body contains enormous communities of microorganisms collectively called the microbiome.
Microbial communities exist in areas such as:
- intestine
- skin
- mouth
Scientists are investigating relationships between microbiomes and:
- digestion
- immunity
- metabolism
- disease
Future treatments may attempt to deliberately modify microbial communities.
However, microbiomes are extremely complex, and correlation does not automatically demonstrate causation.
Emerging Trend 14: AI and Biotechnology
Artificial intelligence and biotechnology are increasingly being combined.
AI systems can help researchers analyze enormous biological datasets.
Potential applications include:
- protein structure prediction
- drug discovery
- genomic analysis
- identifying biological patterns
- designing proteins
- predicting molecular interactions
Biotechnology increasingly generates more data than humans can analyze manually.
Computational tools can help scientists identify patterns and generate hypotheses.
AI Does Not Replace Experiments
Suppose an AI model predicts that a molecule will bind strongly to a cancer-related protein.
That is useful.
But it does not prove that the molecule will become a safe and effective medicine.
Scientists still need:
- laboratory experiments
- toxicity testing
- biological studies
- clinical trials
Therefore:
AI prediction → hypothesis or candidate
not
AI prediction → proven treatment
Emerging Trend 15: DNA Sequencing
The ability to read DNA sequences has improved dramatically.
Sequencing can help scientists:
- diagnose genetic conditions
- identify pathogens
- study evolution
- investigate cancer
- monitor outbreaks
- analyze ecosystems
Future sequencing systems may become increasingly:
- rapid
- portable
- inexpensive
- integrated with healthcare
This creates enormous scientific opportunities—but also major privacy challenges.
Emerging Trend 16: Environmental DNA
Organisms constantly release biological material into their environments.
This can include:
- cells
- skin
- scales
- mucus
- waste
DNA extracted from environmental samples is called environmental DNA, or eDNA.
Scientists can collect water or soil and analyze DNA to detect organisms that may be difficult to observe directly.
Potential uses include:
- monitoring endangered species
- detecting invasive species
- studying biodiversity
- tracking ecosystem change
Emerging Trend 17: Conservation Biotechnology
Biotechnology may increasingly contribute to conservation through:
- genetic monitoring
- eDNA
- assisted reproduction
- biobanking
- genome analysis
- disease management
In unusual situations, cloning or gene editing may also be investigated.
However, biotechnology cannot replace:
- habitat protection
- ecosystem restoration
- pollution reduction
- sustainable resource management
Emerging Trend 18: Biobanks
A biobank stores biological material for future research or conservation.
Samples can include:
- DNA
- cells
- tissues
- blood
- reproductive cells
Biobanks may allow future scientists to study biological material using technologies that do not even exist yet.
This makes biobanking a potentially important bridge between present conservation and future biotechnology.
Emerging Trend 19: Space Biotechnology
Future long-duration space missions will create unusual biological challenges.
Astronauts cannot carry unlimited:
- food
- medicine
- oxygen
- replacement materials
Biotechnology could potentially help produce resources during missions.
Possible applications include:
- growing food
- recycling waste
- producing medicines
- recycling nutrients
- producing materials
- regenerating oxygen
This is sometimes called biomanufacturing for space.
Challenge: Biosafety
As biotechnology becomes more powerful, accidental consequences must be considered.
Biosafety focuses on preventing accidental harm involving biological materials or technologies.
Questions include:
- Could an engineered organism escape?
- Could it survive outside the laboratory?
- Could it affect other species?
- Could genetic material spread?
- Could workers be exposed?
- Can the system be contained?
Safety must therefore be designed into biotechnology from the beginning.
Challenge: Biosecurity
Biosecurity includes measures intended to reduce deliberate misuse or harmful access to biological capabilities.
Many technologies are dual-use.
This means the same knowledge or technology can have beneficial and potentially harmful applications.
For example, tools used to study pathogens can help develop:
- diagnostics
- vaccines
- medicines
But powerful biological capabilities also require responsible controls.
Future biotechnology therefore requires balancing:
scientific openness + beneficial research + appropriate safeguards
Challenge: Unintended Consequences
Living systems are complex.
Changing one biological component can affect others.
For example:
gene edited
↓
protein changes
↓
cellular pathway changes
↓
other biological processes may also change
Similarly, modifying an organism in an ecosystem could affect:
- predators
- prey
- competitors
- disease
- nutrient cycles
This is why new biotechnology requires extensive testing.
Challenge: Evolution
Biological systems evolve.
This means biotechnology does not operate against a static background.
Examples include:
- bacteria evolving antibiotic resistance
- insects evolving resistance to pest-control methods
- viruses evolving
- weeds developing resistance
- organisms adapting to environmental changes
A technology that works today may become less effective later.
Long-term planning must therefore consider evolutionary responses.
Challenge: Inequality
Imagine a biotechnology that can cure a severe genetic disorder but costs $1 million per patient.
Scientifically, the treatment may be highly successful.
Socially, important questions remain:
- Who can access it?
- Who pays?
- Which countries can provide it?
- Could biotechnology increase health inequalities?
Scientific success does not automatically guarantee fair distribution.
Challenge: Intellectual Property
Developing biotechnology can require enormous investment.
Companies may protect inventions through:
- patents
- licensing
- intellectual property rights
These systems can encourage investment and innovation.
However, they can also create questions about:
- access
- pricing
- competition
- ownership of biological inventions
- farmers' access to agricultural technology
Future biotechnology will involve economic questions as well as scientific ones.
Challenge: Regulation
Governments and scientific organizations must decide how emerging technologies should be regulated.
Regulation may need to balance:
innovation
with
safety
and
public interest
Too little oversight could allow harmful applications.
Poorly designed or unnecessarily restrictive regulation could also delay beneficial technologies.
Evidence therefore needs to be continually reviewed as technologies develop.
Challenge: Public Trust
Biotechnology affects areas people care deeply about:
- health
- food
- reproduction
- genetics
- animals
- environment
Public trust can be damaged when information is:
- hidden
- exaggerated
- misleading
- poorly explained
Scientists and biotechnology organizations therefore need clear communication about:
- evidence
- benefits
- risks
- uncertainty
- limitations
Hype vs Evidence
Emerging technologies often receive enormous media attention.
Headlines may claim:
"Scientists discover cure for cancer!"
But perhaps the actual research showed that:
A new treatment reduced tumor growth in cultured cells.
These statements are very different.
When evaluating emerging biotechnology, ask:
What was actually tested?
Cells?
Animals?
Humans?
How large was the study?
Has it been replicated?
What were the side effects?
How long were participants followed?
Has it been independently reviewed?
Technology Readiness
A biotechnology may pass through many stages.
scientific idea
↓
laboratory research
↓
proof of concept
↓
animal/preclinical testing where appropriate
↓
human trials where appropriate
↓
regulatory review
↓
manufacturing
↓
real-world use
A technology succeeding at one stage does not guarantee success at the next.
Predicting Future Applications
Suppose researchers demonstrate that an enzyme can break down a particular plastic efficiently in laboratory conditions.
Weak Prediction
"Plastic pollution will disappear."
There is insufficient evidence.
Better Prediction
"Enzyme-based recycling could become one method for recycling certain plastics if it can be made efficient, economical, and scalable."
The second prediction recognizes both:
current evidence
and
remaining uncertainty.
Scenario 1: Future Medicine
Current evidence shows:
- some gene therapies already treat disease
- CRISPR can make targeted genetic changes
- sequencing is becoming increasingly powerful
- AI can assist biological analysis
- stem-cell technologies continue to improve
A reasonable future prediction is:
Some medical treatments will become increasingly tailored to the molecular and genetic characteristics of individual patients.
This prediction extends existing evidence without claiming that every disease will become personalized or curable.
Scenario 2: Future Agriculture
Current evidence shows:
- genes influencing crop traits can be identified
- gene editing can modify plant genomes
- climate change creates new agricultural pressures
Reasonable prediction:
Gene editing and genomic technologies will likely play an increasing role in developing crops adapted to particular environmental stresses.
Unreasonable prediction:
Biotechnology will completely eliminate crop failure.
Scenario 3: Future Environment
Current evidence shows:
- microorganisms treat wastewater
- enzymes can break down certain pollutants
- biological systems can recover resources
- eDNA can monitor ecosystems
Reasonable prediction:
Biological technologies will increasingly complement physical and chemical methods in environmental monitoring, waste treatment, and resource recovery.
Worked Example 1: Gene Editing
Researchers develop a new gene editor with:
- fewer unintended edits than an older system
- higher editing efficiency
- successful results in cultured human cells
Can we conclude it will become a successful medicine?
Answer
No.
The evidence is promising, but researchers still need to investigate:
- delivery
- toxicity
- immune responses
- effectiveness in organisms
- long-term effects
- manufacturing
- clinical safety
The evidence supports further investigation, not guaranteed medical success.
Worked Example 2: Cultivated Meat
A company reports that cultivated meat uses 80% less land than conventional beef production.
Can we conclude it is 80% more environmentally sustainable?
Answer
No.
Land use is only one environmental factor.
We would also need evidence about:
- energy consumption
- greenhouse gas emissions
- water use
- production materials
- waste
- manufacturing infrastructure
A complete evaluation requires multiple indicators.
Worked Example 3: Future Crops
A gene-edited wheat variety survives drought conditions significantly better than conventional wheat in greenhouse experiments.
What is a reasonable prediction?
Answer
The technology may have potential to improve drought tolerance in agriculture, but field trials are needed.
Greenhouses cannot fully reproduce:
- soil variation
- pests
- weather
- competition
- farming practices
The strength of the prediction should match the strength of the evidence.
Worked Example 4: AI Drug Discovery
An AI system identifies 20 molecules predicted to interact with a bacterial protein.
What should happen next?
Answer
Scientists should experimentally test the molecules.
Useful stages might include:
AI prediction
↓
laboratory testing
↓
toxicity and biological studies
↓
promising candidates identified
↓
further preclinical/clinical development where appropriate
AI can accelerate discovery but cannot replace biological evidence.
Worked Example 5: Environmental Biotechnology
An engineered bacterium can remove 99% of a pollutant from water in laboratory conditions.
Before environmental use, what should scientists investigate?
Answer
They should investigate:
- effectiveness outside the laboratory
- survival of the organism
- ecological effects
- containment
- genetic stability
- possible gene transfer
- treatment cost
- scalability
- remaining waste products
A high laboratory removal percentage alone is insufficient.
Common Mistakes
Mistake 1: "Future biotechnology can be predicted with certainty."
Predictions should describe likelihoods based on current evidence and acknowledge uncertainty.
Mistake 2: "A technology that works in cells will work in humans."
Cell experiments are an early stage of evidence.
Mistake 3: "Newer technology is automatically better."
New technologies must demonstrate advantages through evidence.
Mistake 4: "Biotechnology will solve world hunger."
Food insecurity also involves economics, conflict, infrastructure, distribution, and waste.
Mistake 5: "Biotechnology will solve climate change."
Biotechnology can contribute, but climate change requires changes across energy, transportation, industry, agriculture, land use, and other systems.
Mistake 6: "Natural means safe."
Natural substances and organisms can be harmful.
Safety depends on biological properties and exposure, not simply whether something is natural.
Mistake 7: "Artificial means dangerous."
Engineered technologies should be evaluated using evidence about their actual properties and risks.
Mistake 8: "If something is technically possible, it should automatically be used."
Scientific possibility and ethical acceptability are different questions.
Mistake 9: "Laboratory success means commercial success."
Cost, manufacturing, regulation, scalability, and reliability also matter.
Mistake 10: "One benefit proves a technology is sustainable."
Environmental technologies require broader life-cycle evaluation.
Mistake 11: "AI predictions are scientific proof."
AI can generate useful predictions, but experimental evidence is still required.
Mistake 12: "Scientific progress eliminates uncertainty."
New knowledge often answers some questions while revealing new ones.
Good science identifies uncertainty rather than hiding it.
Check Your Understanding
1. Emerging Biotechnology
Identify five emerging areas of biotechnology.
For each, describe one potential future application.
2. Gene Editing
Explain two ways future gene-editing technologies might improve upon current approaches.
Identify two challenges that must still be addressed.
3. Regenerative Medicine
Explain how these could contribute to regenerative medicine:
- stem cells
- organoids
- tissue engineering
- 3D bioprinting
4. Future Food
Compare two emerging food technologies.
Consider:
- potential benefits
- limitations
- environmental impacts
- consumer acceptance
5. Environmental Biotechnology
Describe three ways biotechnology could contribute to environmental sustainability.
Explain why each must still be evaluated using evidence.
6. AI and Biotechnology
Describe three ways AI could support biotechnology.
Why must AI predictions still be tested experimentally?
7. Risk
Identify four risks or challenges associated with emerging biotechnology.
Classify each primarily as:
- scientific
- environmental
- ethical
- social/economic
Some challenges may belong to more than one category.
8. Evidence
Explain why this statement is scientifically weak:
"Scientists successfully tested a new treatment in cells, so it will soon cure the disease."
Rewrite it as an evidence-based prediction.
9. Global Challenges
Choose one:
- food security
- climate change
- antibiotic resistance
- organ shortages
- emerging diseases
- environmental pollution
Explain how biotechnology could contribute to addressing the problem.
Then explain why biotechnology alone is unlikely to solve it completely.
10. Future Biotechnology Challenge
It is the year 2045.
A biotechnology company develops an engineered microorganism that:
- consumes agricultural waste
- produces biodegradable plastic
- grows rapidly
- can survive outside industrial bioreactors
- reduces production costs by 60%
- has performed successfully for five years in contained facilities
- has never been deliberately released into the environment
- contains several engineered genes
- could potentially exchange genetic material with related microorganisms
Evaluate whether the organism should be used on a much larger scale.
Organize your evaluation under:
Scientific evidence
Potential benefits
Environmental risks
Biosafety
Economic impacts
Sustainability
Uncertainty
Additional evidence needed
Your justified conclusion
Key Terms
- Emerging technology – technology that is new or developing rapidly
- Evidence-based prediction – prediction supported by current scientific observations and evidence
- Precision medicine – use of biological and other patient information to help guide healthcare
- Pharmacogenomics – study of how genetic variation affects drug response
- Regenerative medicine – approaches intended to repair, replace, or regenerate damaged tissues
- Organoid – three-dimensional cellular model reproducing some features of an organ
- Tissue engineering – use of cells, materials, and engineering approaches to construct or repair tissues
- Bioprinting – use of 3D-printing approaches involving cells and biological materials
- Xenotransplantation – transplantation of biological material between different species
- Synthetic biology – engineering or redesign of biological systems
- Biomanufacturing – use of biological systems to manufacture useful products
- Precision fermentation – use of microorganisms to produce specific biological molecules
- Cultivated meat – meat produced by growing animal cells rather than raising an entire animal
- Climate-resilient crop – crop developed to tolerate environmental stresses associated with changing conditions
- Biosensor – system combining biological recognition with a measurable signal
- Phage therapy – use of bacteriophages to target bacteria
- Microbiome – community of microorganisms associated with an organism or environment
- Environmental DNA (eDNA) – DNA collected from environmental samples rather than directly from an organism
- Biobank – stored collection of biological samples and associated information
- Biosafety – prevention of accidental harm involving biological materials
- Biosecurity – measures intended to reduce deliberate misuse or harmful access to biological capabilities
- Dual-use technology – technology capable of both beneficial and potentially harmful applications
- Life-cycle assessment – evaluation of environmental impacts across the stages of a product or process
- Scalability – ability of a technology to function effectively at larger scale
- Technology readiness – degree to which a technology has progressed from research toward practical use
Key Takeaways
- Biotechnology is likely to become increasingly important in medicine, agriculture, food production, environmental management, manufacturing, and conservation.
- Future predictions should be based on current evidence, not speculation alone.
- New gene-editing technologies may provide increasingly precise ways to modify DNA, but delivery and safety remain major challenges.
- Personalized medicine may increasingly use genomic and molecular information to guide treatment.
- Regenerative medicine, stem cells, organoids, tissue engineering, and bioprinting could help repair or replace damaged tissues.
- Biotechnology may contribute to addressing shortages of transplant organs, including through tissue engineering and research into xenotransplantation.
- Synthetic biology and precision fermentation may allow microorganisms to manufacture medicines, foods, fuels, chemicals, and materials.
- Agricultural biotechnology may help develop crops better adapted to drought, heat, disease, and other environmental stresses.
- Biotechnology can contribute to food security, but food insecurity also has major economic, political, distributional, and social causes.
- Environmental biotechnology may improve waste treatment, recycling, pollution management, carbon management, and resource recovery.
- Biosensors and rapid diagnostics could improve disease detection, environmental monitoring, agriculture, and food safety.
- Biotechnology may contribute to addressing antibiotic resistance, including through new diagnostics, medicines, and phage-based approaches.
- AI can accelerate genomic analysis, protein research, and drug discovery, but computational predictions still require experimental testing.
- DNA sequencing and eDNA technologies may increasingly support medicine, outbreak surveillance, ecology, and conservation.
- Powerful biotechnology creates challenges involving biosafety, biosecurity, privacy, regulation, environmental effects, and unintended consequences.
- Because biological systems evolve, the effectiveness of biotechnology can change over time.
- Access to expensive biotechnology raises questions involving justice and inequality.
- Laboratory success does not guarantee practical success; technologies must also demonstrate safety, scalability, reliability, affordability, and real-world effectiveness.
- A technology should not be judged simply as "natural" or "artificial." Its actual evidence, benefits, risks, and alternatives should be evaluated.
- Biotechnology is unlikely to provide single solutions to complex global problems, but it can become an important part of broader scientific, engineering, environmental, and social solutions.